BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:6th Annual Pharma Pricing\, Reimbursement &amp\; Market Access
  2022\n\n15th &amp\; 16th June 2022\, Embassy Suites by Hilton Boston Log
 an Airport Boston\, USA\n\nThis conference will provide an overview of gl
 obal pricing\, market access systems and cost management techniques\, as 
 well as in-depth discussion of some of the most current trends and change
 s. This Conference will bring together top pharmaceutical\, biotechnology
  and regulatory representatives under one roof that will address the key 
 issues of the industry. It will be studied with the help of case studies 
 and industry experiences. Following a raft of health policy reforms impac
 ting pharmaceutical pricing in almost every major country in the EU.\n\nD
 ELEGATE REGISTRATION:\n\nEmail - kavitha@virtueinsight.co.in or TEL: +44-
 20 3509 3779\n\nSTANDARD PRICE - 1 Delegates US $ 1599\n\nFor Group Disco
 unts\, Conference Sponsor\, Exhibition Stall &amp\; Paid Speaker Slot - P
 lease email your interest and queries to kavitha@virtueinsight.co.in\n\nK
 EY SPEAKERS:\n\n\nRICHARD LINER\, Senior Assistant General Counsel\, Baye
 r\nMARK MYERS\, Director\, Healthcare Resources Division\, Office of Cont
 ract Review &amp\; Inspector General\, United States Department of Vetera
 ns Affairs\nJOLIE APICELLA\, Assistant\, U.S. Attorney’s Office\, EDNY\nR
 AHUL GOYAL\, Senior Director\, UnitedHealth Group\nGREG APOSTOL\, Vice Pr
 esident and Head of Market Access\, Alkermes\nMALLORY O’CONNOR\, Executiv
 e Director\, Public Policy\, Mallinckrodt Pharmaceuticals\nBOXIONG TANG\,
  Executive Director\, HEOR\, Global Medical Affairs\, BeiGene\nMARTIN ROS
 T\, Senior Director\, Market Access (Global)\, Pfizer\nKEREN TENENBAUM\, 
 Vice President of Legal &amp\; Compliance - U.S\, Vifor Pharma\nMELVA COV
 INGTON\, Senior Vice President\, Research and Patient Outcomes\, Curio Di
 gital Therapeutics\nKEITH WHITE\, Head\, Global Market Access\, Amylyx Ph
 armaceuticals\nSTUART LEVINE\, Partner\, Chicago Pacific Founders\nHEATHE
 R LEIGH FLANNERY\, Founder &amp\; CEO\, Equideum Health\nROBERT POPOVIAN\
 , Chief Science Policy Officer\, Global Healthy Living Foundation\nAYESHA
  AZAM\, Vice President of Medical Affairs\, Patient Access Network (PAN) 
 Foundation\nPETER BARSCHDORFF\, Vice President\, Deallus\nVIDYA BREEVELD–
 DWARKASING\, Owner\, Keen Access Insights (Former Head of Public Affairs 
 &amp\; Market Access\, Sanofi Pasteur)\nGARY ELLEXSON\, VP Corporate Acco
 unts\, Supernus Pharmaceuticals\nMICHAEL THOMPSON\, President &amp\; CEO\
 , National Alliance of Healthcare Purchaser Coalitions\nANDREW THORRENS\,
  VP / Head of Market Access (US) and Reimbursement\, ImprimisRx\nOMAR DAB
 BOUS\, VP\, Global Health Economics &amp\; Outcomes Research &amp\; Real 
 World Evidence\, AveXis\nFANTA WATERMAN\, Managing Director\, Serrette Br
 own Research &amp\; Consulting\nEVERETT CROSLAND\, Chief Commercial Offic
 er\, Cognito Therapeutics\nFABRIZIO GIANFRATE\, Professor of Health Econo
 mics and Outcome Research - Market Access Independent Consultant - Ex Pay
 er (Italy)\n\nKEY THEMES DISCUSSED:\n\n\nLessons learnt from the pandemic
  - Formulating your best market access strategy\nPharma pricing and marke
 t access in the US: concepts\, components\, and future\nPrioritising Pati
 ents! - Adding value through an innovative patient-centred approach\nImpo
 rtance of working together: Stakeholders- Industry\, Payers\, Physicians 
 and Patients\nImproving patient and market access through the development
  of targeted value propositions\, comprehensive contract assessment\nMark
 et access challenges facing the industry\nEvidence Generation - The strat
 egic rigor and creativity applied to evidence generation\nHow can payers 
 and industry work together and importance for the same\nUnderstanding - p
 ayers’ perspective\nAdvocating and collaborating with payers for value in
  a new era\nHow price affects market access and learn on how to set price
 s for optimal access &amp\; returns.\nDeveloping risk-sharing reimburseme
 nt models and value-based pricing\nPatient engagement and adherence withi
 n the environment\nHow to use the data sources and observational research
  for effective safety analysis\nDwell ahead of regulatory developments &a
 mp\; improving your strategies in a cost-effective way\nBe part of a majo
 r networking opportunity\n\nWHO SHOULD ATTEND:\n\nSenior Vice Presidents\
 , Vice Presidents\, Senior Executives\, Global Heads\, Heads\, Directors\
 , Senior Managers\, Managers of:\n\nPricing\, Reimbursement\, Market Acce
 ss\, Commercial Pricing\, Pricing Strategists\, Health Economics\, Outcom
 es Research\, Regulatory Affairs\, Governmental Affairs\, Public Affairs\
 , Public Policy Directors\, Operations\, Governmental bodies\, Regulatory
  bodies\n\nGet more from the event\, with a broader scope bringing the wh
 ole communications value chain together. Enjoy and make the best out of o
 ur dedicated networking time\, meet the leading international vendors sho
 wcasing the products of tomorrow in the co-located exhibition. Expand you
 r knowledge of the latest business models and strategies in the high-leve
 l conference.\n\n&nbsp\;\n
DTEND:20220616T170000
DTSTAMP:20260512T225914Z
DTSTART:20220615T092900
LOCATION:Embassy Suites by Hilton Boston at Logan Airport\, 207\, Porter S
 treet\, Suffolk County\, 02128\,
SEQUENCE:0
SUMMARY:6th Annual Pharma Pricing\, Reimbursement &amp\; Market Access 202
 2\n15th &amp\; 16th June 2022\, Embassy Suites by Hilton Boston Logan Air
 port Boston\,...
UID:554dd9e9-ad84-4c97-840e-f2fbdb6bddad
END:VEVENT
END:VCALENDAR
